Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer (Q36067677)

12 August 2017

Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer (English)

1 reference

12 August 2017

Ann H Klopp

1

1 reference

12 August 2017

Jennifer Moughan

2

1 reference

12 August 2017

Lorraine Portelance

3

1 reference

12 August 2017

Brigitte E Miller

4

1 reference

12 August 2017

Mohammad R Salehpour

5

1 reference

12 August 2017

Evangeline Hildebrandt

6

1 reference

12 August 2017

Jenny Nuanjing

7

1 reference

12 August 2017

David D'Souza

8

1 reference

12 August 2017

Luis Souhami

9

1 reference

12 August 2017

William Small

10

1 reference

12 August 2017

Rakesh Gaur

11

1 reference

12 August 2017

Anuja Jhingran

12

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 May 2013

1 reference

International Journal of Radiation Oncology Biology Physics

12 August 2017

1 reference

12 August 2017

86

1 reference

12 August 2017

1

1 reference

12 August 2017

83-90

1 reference

Irradiation induces bone injury by damaging bone marrow microenvironment for stem cells.

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572833

Chemoradiotherapy for cervical cancer in 2010

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572833

Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572833

Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572833

Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572833

Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572833

Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4572833

Cervix regression and motion during the course of external beam chemoradiation for cervical cancer

23 September 2018

1 reference

12 December 2020

1 reference

12 December 2020

Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix

1 reference

12 December 2020

Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix

1 reference

12 December 2020

Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix

1 reference

12 December 2020

Preliminary analysis of RTOG 9708: adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer

1 reference

12 December 2020

Final analysis of RTOG 9708: Adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer

1 reference

12 December 2020

10.1016/J.IJROBP.2013.01.017

Identifiers

DOI

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

23582248

1 reference